Saturday Mar 28, 2026
New Advances in Cancer – A Discussion with Dr. Raza Bokhari, Medicus Pharma
Dr. Raza Bokhari the CEO of Medicus Pharma, a biotech/life sciences company focused on advancing the clinical development programs in the area of oncology joins eHealth Radio and the Cancer Information and Health News Channels. Today, he will discuss some significant progress in ongoing research that can pave the way for better treatment of skin and prostate cancers.
Listen to interview with host Eric Michaels & guest Dr. Raza Bokhari discuss the following:
- Medicus Pharma has been making huge progress in cancer treatment most recently in the areas of prostate and skin cancer. You recently announced significant news with your new chemo cancer patch for a common skin cancer called Skinject. What have the results shown so far?
- From what I understand, this type of cancer, basal cell carcinoma, is treated with invasive surgery, will the hope be that Skinject replaces the knife?
- What lies ahead for Skinject? How much more trials would be needed and when can we see this available for patients?
- Medicus has also been making advances in prostate cancer with a drug Medicus is developing. Give us more information about the drug and how does it address this common cancer in men?
- What are the next steps for your prostate drug? Where can folks learn more about trial for that and Skinject?
Dr. Raza Bokhari – a physician turned serial entrepreneur - has a demonstrated successful track record in aggregating and accelerating life sciences, healthcare services and Pharmaceutical R&D companies.
He previously served as Executive Chairman and CEO of FSD Pharma (Nasdaq: HUGE), where his strategies successfully pivoted the company out of medicinal cannabis and into a clinical stage pharmaceutical R&D, a transition marked by a NASDAQ listing in January 2020, and raising nearly $100M institutional capital to fuel growth and expansion.
Dr. Bokhari has a Doctor of Medicine degree from the University of Punjab, Rawalpindi Medical College, and an Executive MBA from Temple University, Fox School of Business & Management.
In addition to his corporate roles, Dr. Bokhari serves as the Vice Chairman of the World Affairs Council of Philadelphia. He formerly served on the Board of Temple University’s Fox School of Business and Management as Chairman of the Executive Advisory Committee and was a Trustee of the esteemed Franklin Institute and Foreign Policy Research Institute.
Dr. Bokhari, through his family foundation, believes in giving back and investing in the community. In recognition of a $1 million gift, he made to his alma mater, Temple University, its Fox Business School named the Innovation & Entrepreneurship Institute Suite in his honor. The school acknowledged Dr. Bokhari in 2018 by naming him a Centennial Honoree, a special collection of entrepreneurs, visionaries, and disruptors who helped shape the Fox School and the business world since 1918.
Website: https://medicuspharma.com
Social Media Links:
Linkedin: https://www.linkedin.com/company/medicus-pharma-ltd
X: https://x.com/MedicusLtd
People also listened to this: April Is Autism Month: Exploring Why Early Applied Behavior Analysis (ABA) Intervention is Critical in the First Five Years
No comments yet. Be the first to say something!